Chromatography Forum of the Delaware Valley Dal Nogare Award
The 2017 Chromatography Forum of the Delaware Valley Dal Nogare Award will be presented Monday morning at Pittcon 2017 to Professor Andras Guttman from the Csaba Horváth Laboratory of Bioseparation Sciences at the University of Debrecen in Hungary.
Room W183A, 8:30 a.m.
The 2017 Chromatography Forum of the Delaware Valley Dal Nogare Award will be presented Monday morning at Pittcon 2017 to Professor Andras Guttman from the Csaba Horváth Laboratory of Bioseparation Sciences at the University of Debrecen in Hungary. The award will be presented by Mary Ellen McNally of EI DuPont de Nemours and Company.
The Chromatography Forum of the Delaware Valley chooses award recipients based on their contributions to the fundamental understanding of the chromatographic process. The award was established in honor of Stephen Dal Nogare, who died in 1968 after serving for six months as president of the Chromatography Forum. Guttman, who will be the 45th recipient of the award, is being recognized for his work with the theory and application of capillary electrophoresis separations of biomolecules such as glycoproteins and carbohydrates.
A session of oral presentations will follow the award presentation, with talks to be given by Guttman on analytical glycomics (the study of carbohydrate structures in biological systems), Barry L. Karger (Northeastern University) on the coupling of column separations to mass spectrometry for biotherapeutic applications, Frantisek Svec (The Molecular Foundry, Lawrence Berkeley National Laboratory) on the use of porous polymer-based monolithic columns, Milos V. Novotny (Indiana University) on capillary electrophoresis with laser-induced fluorescence detection, and John R. Yates (The Scripps Research Institute) on studying the dynamics of protein networks in Saccharomyces cerevisiae.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
